Registration

TODD STRATEGY GROUP for ASTELLAS PHARMA US, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Value of Prescription Drugs. Drug pricing. Biopharmaceutical Innovation and Patient Policy Issues. PSA Screening for HIM Act. H.R.8223/S.4246 - Advancing Menopause Care and Mid-Life Womens Health Act. Pharmacy Benefit Manager reform. Issues related to March-In

LobbyistCovered position, as disclosed
ERIC BERGREN New Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker
KATHERINE FLEMING COTTON New Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie
PAUL EDATTEL New Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
TED LEHMAN New Chief of Staff, Senator Tillis; Senate Judiciary Committee-Counsel, then Chief Counsel for Nominations and Senior Counsel; Senate Judiciary Committee-Staff Assistant and Legislative Assistant
KIMBERLY LINTHICUM New Legislative Director, Representative Bob Franks; Legislative Correspondent, Representative Charles Taylor; Legislative Correspondent, Representative Bill Martini
JEFF LUCAS New Health Policy Advisor, Senator Bill Cassidy; Legislative Assistant/Sr. Legislative Assistant/Legislative Correspondent, Representative Larry Bucshon
TAYLOR SEXTON New Advisor to the Assistant Secretary for Preparedness & Response, HHS; Advisor to the Assistant Secretary of Legislation, HHS; Health Care Policy Fellow, Representative Michael Burgess
DANIEL M TODD New Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid
NICHOLAS UEHLECKE New Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee

Bills named: S. 4246 (118th), H.R. 8223 (118th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
ASTELLAS PHARMA INC. (THROUGH 100% OWNERSHIP OF ASTELLAS US HOLDING, INC.) Japan Japan 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.